About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

VectorY Therapeutics Announces Multiple Presentations at Upcoming American Society of Gene and Cell Therapy Annual Meeting 2025

VectorY Therapeutics (VectorY), a biotechnology company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, today announced that it will have four featured data presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting being held May 13-17, 2025 in New Orleans, Louisiana.

"Our presentations at ASGCT showcase the outstanding work of VectorY scientists and the scope of our internal research and technical capabilities,” stated Sander van Deventer, M.D., Ph.D., president of research and development at VectorY. “We are particularly proud of our exciting preclinical data in amyotrophic lateral sclerosis (ALS), Huntington’s disease, and of our optimized AAV & baculovirus production process for one-time administration of our vectorized antibody approach.”

Specific details on VectorY’s presentations taking place at ASGCT 2025 include:

Poster Title: AAV-mediated delivery of an intrabody targeting TDP-43 for Amyotrophic Lateral Sclerosis therapy (AMA2191)

Presenter: Paula Miranda, Ph.D., MBA, Director Pre-Clinical Translation

Poster Session Title: Wednesday Poster reception

Poster #: 1041

Date and Time: Wednesday, May 14th, 5:30-7:00 p.m. CT

Poster Title: AAV-Delivered Anti-PC-OxPL Antibody Fragments as a Novel Therapeutic Approach to Target ALS (AMA233)

Presenter: Andreia Duarte, Ph.D., Sr. Scientist Discovery

Poster Session Title: Wednesday Poster reception

Poster #: 1424

Date and Time: Wednesday, May 14th, 5:30-7:00 p.m. CT

Poster Title: Targeting misfolded mutant HTT protein with vectorized antibodies for the treatment of Huntington Disease (AMA2141)

Presenter: Andreia Duarte, Ph.D., Sr. Scientist Discovery

Poster Session Title: Thursday Poster reception

Poster #: 1920

Date and Time: Thursday, May 15th, 5:30-7:00 p.m. CT

Poster Title: An Optimized Baculovirus Generation Process and Novel ITR-Transgene Design for High Quality AAV Production Using the Insect Cell Production Platform (AMA1395)

Presenter: Femke Hoeksema, Ph.D., Director Process Development

Poster Session Title: Thursday Poster reception

Poster #: 1969

Date and Time: Thursday, May 15th, 5:30-7:00 p.m. CT

About VectorY

VectorY is on a mission to provide people with neurodegenerative diseases a longer, better life by creating transformative vectorized antibody treatments. Our platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS. Unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing and neuroscience drives the rapid development of much needed disease-modifying therapies for neurodegenerative diseases such as ALS and Huntington’s disease. For more information, see www.vectorytx.com.

"Our presentations at ASGCT showcase the outstanding work of VectorY scientists and the scope of our internal research and technical capabilities,” stated Sander van Deventer, M.D., Ph.D., president of research and development at VectorY.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.